Imidazolidinones and Imidazolidine-2,4-diones as Antiviral Agents

Sharada Prasanna Swain, Sandeep Mohanty


Imidazolidinones and imidazolidine-2,4-diones are important classes of heterocyclic compounds that possess potent activities against several viruses such as dengue virus, enterovirus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV). The first imidazolidinone derivative as an anti-HIV agent was reported in 1996. Imidazolidinones inhibit HIV aspartic protease activity, and also act as CCR5 co-receptor antagonists. Significant effort has been devoted to the design of various imidazolidinone analogues that are active against drug-resistant HIV strains, with fewer side effects. Different scaffolds have been designed through both rational drug design strategies and computer-aided drug design. Imidazolidinones have been found to be potent against HIV, and preclinical studies are currently in progress. There are some reports of imidazolidinones as having both anti-HCV and anti-dengue virus activity, and more research has yet to be done along these lines. These compounds inhibit NS3 serine protease of HCV, and NS2B-NS3 protease of dengue virus. Pyridyl-imidazolidinones possess very specific and potent activity against human enterovirus 71 (EV71) by targeting the EV71 capsid protein VP1, and inhibiting viral adsorption an...Continue Reading


Sep 4, 2019·Chemistry & Biodiversity·Yurii KorniiVolodymyr Brovarets
Mar 3, 2020·Organic & Biomolecular Chemistry·Filip StanekMaciej Stodulski


Jan 1, 1992·Life Sciences·J A TerrónC M Villalón
Oct 1, 1988·Journal of Medicinal Chemistry·S S NikamD L Nelson
Sep 27, 1985·Science·J M HogleD J Filman
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·N E KohlI S Sigal
Aug 1, 1986·The Biochemical Journal·A J Barrett, J K McDonald
May 1, 1986·Antimicrobial Agents and Chemotherapy·H Hof, J Ströder
Jan 1, 1973·Journal of Pharmaceutical Sciences·W J Jusko, G P Lewis
May 1, 1983·The Journal of Antimicrobial Chemotherapy·C C Sanders
Apr 15, 1995·Lancet·V S KitchenJ N Weber
Oct 1, 1994·Biopharmaceutics & Drug Disposition·Y N WongS M Huang
May 28, 1993·Science·R A Weiss
Apr 14, 1999·Bioorganic & Medicinal Chemistry Letters·E M NaylorA E Weber
Sep 3, 1999·Antimicrobial Agents and Chemotherapy·D C PevearJ M Groarke
Jun 14, 1996·The Journal of Organic Chemistry·Man-kit Leung MkHsiang-Ju Hsiao
Oct 2, 2002·The Journal of Infectious Diseases·Tzou-Yien LinCheng-Hsun Chiu
Apr 10, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Nidia AlvarezPatrice Le Pape
Aug 26, 2004·Antimicrobial Agents and Chemotherapy·Shin-Ru ShihYu-Sheng Chao
Sep 24, 2004·Bioorganic & Medicinal Chemistry Letters·Jyh-Haur ChernShin-Ru Shih
Oct 16, 2004·Bioorganic & Medicinal Chemistry Letters·Wieslaw M KazmierskiLois Wright
Jul 16, 2005·Bioorganic & Medicinal Chemistry Letters·Ho-Jane ShueGeoffrey B Varty
Dec 19, 2007·Accounts of Chemical Research·Stéphane G OuelletDavid W C MacMillan
Jan 16, 2008·Journal of Biomedical Science·Tzu-Chun ChenShin-Ru Shih

Related Concepts

CCR5 Receptor Antagonists
CCR5 Co-receptor Antagonist [EPC]
Heterocyclic Compounds
Ethylene urea

Related Feeds


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Yanhong WeiShaoyong Ke
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Xue-yong HuangBian-li Xu
© 2020 Meta ULC. All rights reserved